Reproductive counselling for MS: A rationale

International MS Journal

Volumn 10, Issue 2, 2003, Pages 52-59

  Dwosh, E ^a   Guimond, C ^a   Sadovnick, A D ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Multiple sclerosis; Pregnancy management; Psychosocial issues; Reproductive counselling; Therapy

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; BACLOFEN; BETAMETHASONE; CARBAMAZEPINE; CORTICOSTEROID; CORTICOTROPIN; DANTROLENE; DEXAMETHASONE; DISEASE MODIFYING AGENT; DRUG; FLUOXETINE; GABAPENTIN; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON; ISONIAZID; LOPERAMIDE; METHYLPREDNISOLONE; OXYBUTYNIN; PEMOLINE; POTASSIUM CHANNEL BLOCKING AGENT; PREDNISONE; PROPRANOLOL; PYRIDOXINE; SILDENAFIL; TIZANIDINE; TOLTERODINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; YOHIMBINE;

BREAST FEEDING; CONSANGUINEOUS MARRIAGE; CONTRACEPTION; EUROPE; FAMILY HISTORY; FEMALE; FERTILITY; FOOD AND DRUG ADMINISTRATION; HUMAN; INHERITANCE; MULTIPLE SCLEROSIS; PALLIATIVE THERAPY; PARENT COUNSELING; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SOCIAL ASPECT;

COUNSELING; FEMALE; HUMANS; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCTIVE BEHAVIOR;

EID: 0037498187     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.
2. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989; 112:1419-1428.
3. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991; 114: 1045-1056.
4. Ebers GC, Koopman WJ, Hader W, Sadovnick AD, Kremenchutzky M, Mandalfino P et al. The natural history of multiple sclerosis: a geographically based study. 8. Familial multiple sclerosis. Brain 2000; 123: 641-649.
5. Kurtzke JF. Rating neurological impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 1983; 33: 1144-1152.
6. Stockley IH (ed). Stockley's Drug Interactions, 6th edition. London: Pharmaceutical Press, 2002.
7. Malanga GA, Gangemi E. Intracranial venous thrombosis in a patient with multiple sclerosis: a case report and review of contraceptive alternatives in patients with disabilities. Am J Phys Med Rehabil 1994; 73: 283-285.
8. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 321-333.
9. Damek DM, Shuster EA. Pregnancy and multiple sclerosis: review. Mayo Clin Proc 1997; 72: 977-989.
10. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999, 5: 418-427.
11. Davis RK, Maslow AS. Multiple sclerosis in pregnancy: a review. Obs Gyn Surv 1992; 47: 290-296.
12. Gilmore J, Pennell PB, Stern BJ. Medication use during pregnancy for neurologic conditions. Neurol Clin 1998; 16: 189-206.
13. Bader AM. Neurologic and neuromuscular disease in the obstetric patient. Anesthesiology Clinics of North America 1998; 16: 459-476.
14. Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 1988; 259: 3441-3443.
15. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998;339:285-291.
16. Leary SM, Thompson AJ. Current management of multiple sclerosis. Int J Clin Pract 2000; 54:161-169.
17. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
18. National Multiple Sclerosis Society. Source Book Anaesthesia. Available at: www.nationalmssociety. org/Sourcebook-Anesthesia.asp (last accessed 6 March 2003).
19. Poser S, Raun NE, Wikstrom J, Poser W. Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 1979; 59: 108-118.
20. Poser S, Poser W. Multiple sclerosis and gestation. Neurology 1983; 33: 1422-1427.
21. Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remitting patients. J Neurol Neurosurg Psychiatry 1993; 56: 1062-1065.
22. Sadovnick AD, Eisen K, Hashimoto SA, Farquhar R, Yee IM, Hooge J et al. Pregnancy and multiple sclerosis. A prospective study. Arch Neurol 1994; 51: 1120-1124.
23. Tillman AJB. The effect of pregnancy on multiple sclerosis and its management. Proc Assoc Res Nerv Ment Dis 1950; 28: 548-582.
24. Schapira K, Poskanzer DC, Newell DJ, Miller H. Marriage, pregnancy, and multiple sclerosis. Brain 1966; 89: 419-428.
25. Leibowitz U, Antonovsky A, Kats R, Alter M. Does pregnancy increase the risk of multiple sclerosis? J Neurol Neurosurg Psychiatry 1967; 30: 354-357.
26. Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990; 47: 738-742.
27. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis - a 3-year prospective study. J Neurol 1994; 241: 228-233.
28. Birk K, Rudick R. Pregnancy and multiple sclerosis. Arch Neurol 1986; 43: 719-726.
29. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728-1730.
30. Ebers GC, Sadovnick AD, Risch N. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995; 377: 150-151.
31. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DAS. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996; 119: 449-455.
32. Carton H, Vlietinck R, Debruyne J, De Keyser J, D'Hooghe M-B, Loos R et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 1997; 62: 329-333.
33. Ebers GC, Yee IML, Sadovnick AD, Duquette P and the Canadian Collaborative Study Group. Conjugal multilple sclerosis: population-based prevalence and recurrence risks in offspring. Ann Neurol 2000; 48:927-931.
34. Robertson NP, O'Riordan JI, Chataway J, Kingsley DPE, Miller DH, Clayton D et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997; 349: 1587-1590
35. Sadovnick AD, Bulman D, Ebers GC. Parent-child concordance in multiple sclerosis. Ann Neurol 1991; 29: 252-255.
36. Sadovnick AD, Yee IML, Ebers GC and the Canadian Collaborative Study Group. Recurrence risks to sibs of MS index cases: impact of consanguineous mating. Neurology 2001; 56: 784-785.
37. Dyment DA, Cader MZ, Willer CJ, Risch N, Sadovnick AD, Ebers GC. A multigenerational family with multiple sclerosis. Brain 2002; 125: 1474-1482.
38. Huntley A, Ernst E. Commentary and alternate therapies for treating multiple sclerosis symptoms: a systematic review. Complement Ther Med 2000; 8: 97-105.
39. Merck. Chapter 249, normal pregnancy, labor and delivery. In: Manual of Diagnosis and Therapy. New Jersey: Merck and Co. Inc., 1995-2001. Available at: www.merck.com/pubs/mmanual/tables/249tb 1.htm (last accessed 12 March 2003).